Ariad Pharmaceuticals, Inc. Stock
Equities
US04033A1007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2017 | Takeda Pharmaceutical : Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal | RE |
2014 | Dai ichi Life Insurance : U.S. futures flat with Dow, S&P at record levels | RE |
Managers | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- Stock